Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 600
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 42%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

InSilico Medicine Cayman TopCo operates as an artificial intelligence (AI)-based biotech company that helps to develop and manufacture novel drugs in Hong Kong, the United States, the United Kingdom, Mainland China, and internationally. The company develops solutions to discover and develop drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. It also offers Pharma.AI platform, a commercially end-to-end genera...

Phone: 852 1626 5937 957
Address:
Building 8W, Phase 2, Unit 310, 3/F Hong Kong Science Park Pak Shek Kok, Hong Kong, Hong Kong
Markus_Montag
Markus_Montag Mar. 16 at 9:36 PM
$RXRX I hear lots of good things about AI for drug discovery. Why is this stock so low? I believe it is the leader in the space but others trade way better $GENB and $ISLMF
1 · Reply
Latest News on ISLMF
No data available.
Markus_Montag
Markus_Montag Mar. 16 at 9:36 PM
$RXRX I hear lots of good things about AI for drug discovery. Why is this stock so low? I believe it is the leader in the space but others trade way better $GENB and $ISLMF
1 · Reply